» Articles » PMID: 35861626

Cancer Effects of Low to Moderate Doses of Ionizing Radiation in Young People with Cancer-Predisposing Conditions: A Systematic Review

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Moderate to high doses of ionizing radiation (IR) are known to increase the risk of cancer, particularly following childhood exposure. Concerns remain regarding risks from lower doses and the role of cancer-predisposing factors (CPF; genetic disorders, immunodeficiency, mutations/variants in DNA damage detection or repair genes) on radiation-induced cancer (RIC) risk. We conducted a systematic review of evidence that CPFs modify RIC risk in young people. Searches were performed in PubMed, Scopus, Web of Science, and EMBASE for epidemiologic studies of cancer risk in humans (<25 years) with a CPF, exposed to low-moderate IR. Risk of bias was considered. Fifteen articles focusing on leukemia, lymphoma, breast, brain, and thyroid cancers were included. We found inadequate evidence that CPFs modify the risk of radiation-induced leukemia, lymphoma, brain/central nervous system, and thyroid cancers and limited evidence that BRCA mutations modify radiation-induced breast cancer risk. Heterogeneity was observed across studies regarding exposure measures, and the numbers of subjects with CPFs other than BRCA mutations were very small. Further studies with more appropriate study designs are needed to elucidate the impact of CPFs on RIC. They should focus either on populations of carriers of specific gene mutations or on common susceptible variants using polygenic risk scores.

Citing Articles

The Impact of a Breast Cancer Risk Assessment on the Decision for Gender-Affirming Chest Masculinization Surgery in Transgender and Gender-Diverse Individuals: A Pilot Single-Arm Educational Intervention Trial.

Cortina C, Purdy A, Brazauskas R, Stachowiak S, Fodrocy J, Klement K Ann Surg Oncol. 2024; 31(11):7474-7482.

PMID: 38940898 PMC: 11452287. DOI: 10.1245/s10434-024-15701-2.


CanCHD Study of Hematopoietic Cancers in Children With and Without Genetic Syndromes.

Hasan M, Ganni E, Liu A, Guo L, Mackie A, Kaufman J J Am Heart Assoc. 2023; 13(1):e026604.

PMID: 38156460 PMC: 10863797. DOI: 10.1161/JAHA.122.026604.


Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: what do we tell patients?.

Lee M, Robson M J Natl Cancer Inst. 2023; 115(11):1243-1245.

PMID: 37603726 PMC: 10637031. DOI: 10.1093/jnci/djad129.


The Landscape of Single Nucleotide Polymorphisms in Papillary Thyroid Carcinoma.

Kyrodimos E, Chrysovergis A, Mastronikolis N, Papanastasiou G, Tsiambas E, Spyropoulou D Cancer Diagn Progn. 2023; 3(1):26-30.

PMID: 36632585 PMC: 9801452. DOI: 10.21873/cdp.10175.

References
1.
Clarke C, Morton L, Lynch C, Pfeiffer R, Hall E, Gibson T . Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer. 2013; 109(1):280-8. PMC: 3708563. DOI: 10.1038/bjc.2013.294. View

2.
Watt G, Reiner A, Smith S, Stram D, Capanu M, Malone K . Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast Cancer. JAMA Netw Open. 2019; 2(9):e1912259. PMC: 6777239. DOI: 10.1001/jamanetworkopen.2019.12259. View

3.
Kleinerman R . Radiation-sensitive genetically susceptible pediatric sub-populations. Pediatr Radiol. 2008; 39 Suppl 1:S27-31. PMC: 2656401. DOI: 10.1007/s00247-008-1015-6. View

4.
Journy N, Roue T, Cardis E, Ducou Le Pointe H, Brisse H, Chateil J . Childhood CT scans and cancer risk: impact of predisposing factors for cancer on the risk estimates. J Radiol Prot. 2016; 36(1):N1-7. DOI: 10.1088/0952-4746/36/1/N1. View

5.
Bhatti P, Doody M, Rajaraman P, Alexander B, Yeager M, Hutchinson A . Novel breast cancer risk alleles and interaction with ionizing radiation among U.S. radiologic technologists. Radiat Res. 2010; 173(2):214-24. PMC: 2922870. DOI: 10.1667/RR1985.1. View